Cancer-Associated Fibroblasts Exert Proangiogenic Activity in Merkel Cell Carcinoma.
Journal
The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720
Informations de publication
Date de publication:
06 2023
06 2023
Historique:
received:
22
09
2021
revised:
01
11
2022
accepted:
05
12
2022
medline:
23
5
2023
pubmed:
27
12
2022
entrez:
26
12
2022
Statut:
ppublish
Résumé
The tumor microenvironment is a complex niche enveloping a tumor formed by extracellular matrix, blood vessels, immune cells, and fibroblasts constantly interacting with cancer cells. Although tumor microenvironment is increasingly recognized as a major player in cancer initiation and progression in many tumor types, its involvement in Merkel cell carcinoma (MCC) pathogenesis is currently unknown. In this study, we provide a molecular and functional characterization of cancer-associated fibroblasts (CAFs), the major tumor microenvironment component, in patient-derived xenografts of patients with MCC. We show that subcutaneous coinjection of patient-derived CAFs and human MCC MKL-1 cells into severe combined immunodeficient mice significantly promotes tumor growth and metastasis. These fast-growing xenografts are characterized by areas densely populated with human CAFs, mainly localized around blood vessels. We provide evidence that the growth-promoting activity of MCC-derived CAFs is mediated by the aminopeptidase A/angiotensin II and III/angiotensin II type 1 receptor axis, with the expression of aminopeptidase A in CAFs being a triggering event. Together, our findings point to aminopeptidase A as a potential marker for MCC prognostic stratification and as a candidate for therapeutic intervention.
Identifiants
pubmed: 36572089
pii: S0022-202X(22)02896-2
doi: 10.1016/j.jid.2022.12.006
pii:
doi:
Substances chimiques
Glutamyl Aminopeptidase
EC 3.4.11.7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
965-976.e15Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.